Many women are looking for ways to ease the symptoms of menopause. One common way is through hormone therapy. I recent found a web resource created by The Federal Drug Administration that I want to share with you. This website lists the different types of hormone therapies – estrogen-only, progestin-only, and medications that combine estrogen and progestin.
The federal agency recommends that women interested in hormone therapy should consult their doctor before starting a regimen. Some research has found that hormone therapy may increase women’s risk of blood clots, heart attacks, strokes, breast cancer, and gallbladder disease. Additionally, estrogen-only therapy also may increase the chances that a woman who has a uterus may develop endometrial cancer. Therefore, women should take the lowest dose that provides relief for them for the shortest time. Women also should not take hormone therapy if they are pregnant, have unusual vaginal bleeding, have (or previously ha...
Current or recent past users of hormonal replacement therapy (HRT) have a higher risk of being diagnosed with breast cancer. Before the link between HRT use and breast cancer risk was established, many postmenopausal women took HRT for many years to ease menopausal symptoms (hot flashes, fatigue) and to reduce bone loss. Since 2002, when research linked HRT and risk, the number of women taking HRT has dropped dramatically. Still, many women continue to use HRT to handle bothersome menopausal symptoms.
There are two main types of HRT:
combination HRT contains the hormones estrogen and progesterone
estrogen-only HRT contains only estrogen
Each type of HRT seems to have a different effect on breast cancer risk.
Combination HRT increases breast cancer risk by about 75%, even when used for only a short time. Combination HRT also increases the likelihood that the cancer may be found at a more advanced stage, as well as increasing the risk that a woman diagnosed with breast cancer will die...
A stunning report in the December 15, 2006 New York Times , citing strong evidence linking hormone replacement therapy (HRT) with breast cancer , spawned a tidal wave of media coverage. It seems every paper across America picked up the story, which came out of the annual San Antonio Breast Cancer Symposium. The news detailed long-term results of the landmark Women's Health Initiative (WHI), prematurely halted in 2002 when researchers found overwhelming evidence of particular health risks among hormone users, most notably for stroke and breast cancer. In San Antonio, the results of further studies seemed to confirm those risks with long-term hard data: rates for the most common form of breast cancer dropped precipitously between August 2002 and December 2003, when many women stopped HRT. This drop of 15 percent in just 16 months is the biggest decline in any specific type of cancer in any one year–ever. Pretty convincing, huh? If you were still on HRT, this was another big wak...
You should knowAnswers to your question are meant to provide general health information but should not replace medical advice you receive from a doctor. No answers should be viewed as a diagnosis or recommended treatment for a condition. Content posted by community members does not necessarily reflect the views of Remedy Health Media, which also reserves the right to remove material deemed inappropriate.